SMis 16th Annual Pain Therapeutics Meeting to Feature Key Updates from UCL on Translational Biomarkers Following Recent Clinical Breakthrough
Summary
Spotlighting on translational biomarkers, Dr Koltzenberg will provide exclusive updates into nerve excitability profiling (NEP) and its use in studying ion, potassium and different subtypes of sodium channels in rodents and primates, including humans in vivo and in vitro.Targeting an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2016 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery.With a focus on showcasing the latest clinical advancements in drug therapy, the agenda for 2016 will feature a special address from University College London following on from their recent study, which revealed that blocking the stress protein in mice reduced chronic pain.Spotlighting on translational biomarkers, Dr Koltzenberg will provide exclusive updates into nerve excitability profiling (NEP) and its use in studying ion, potassium and different subtypes of sodium channels in rodents and primates, including humans in vivo and in vitro.Targeting an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2016 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery.